SIMPLEX TRADING, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X951. A total of 2 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$432
+260.0%
8,300
+336.8%
0.00%
Q2 2023$120
-95.4%
1,900
-96.0%
0.00%
-100.0%
Q1 2023$2,599
+35.7%
48,000
+32.6%
0.00%0.0%
Q4 2022$1,915
-99.9%
36,2000.0%0.00%0.0%
Q3 2022$1,684,000
+446.8%
36,200
+570.4%
0.00%
Q2 2022$308,000
-62.4%
5,400
-59.7%
0.00%
-100.0%
Q1 2022$819,000
-35.1%
13,400
-44.4%
0.00%0.0%
Q4 2021$1,261,000
+147.7%
24,100
+100.8%
0.00%
Q3 2021$509,000
+4.1%
12,0000.0%0.00%
Q2 2021$489,000
-10.4%
12,000
+7353.4%
0.00%
-100.0%
Q1 2021$546,000
-27.8%
161
-32.4%
0.00%0.0%
Q4 2020$756,000
-47.8%
238
-57.8%
0.00%
-50.0%
Q3 2020$1,447,000
+6.4%
564
+6.4%
0.00%0.0%
Q2 2020$1,360,000
+61.3%
530
-3.5%
0.00%
+100.0%
Q1 2020$843,000
-94.8%
549
-88.3%
0.00%
-97.1%
Q4 2019$16,105,000
+2008.0%
4,694
+358.4%
0.04%
+1650.0%
Q3 2019$764,000
-9.9%
1,024
+56.6%
0.00%0.0%
Q2 2019$848,000
+208.4%
654
+189.4%
0.00%
+100.0%
Q1 2019$275,000
+47.1%
226
+37.0%
0.00%0.0%
Q4 2018$187,000
+46.1%
165
+179.7%
0.00%
Q3 2018$128,000
-86.8%
59
-89.2%
0.00%
-100.0%
Q2 2018$968,000
+1412.5%
548
-23.7%
0.00%
+33.3%
Q1 2018$64,000
+128.6%
718
+301.1%
0.00%
+200.0%
Q4 2017$28,000
-34.9%
179
-59.2%
0.00%
-50.0%
Q3 2017$43,000
+437.5%
439
+509.7%
0.00%
Q2 2017$8,000
-81.4%
72
+100.0%
0.00%
-100.0%
Q1 2017$43,000
-50.6%
36
-77.2%
0.00%
-60.0%
Q4 2016$87,000
-92.5%
158
-87.3%
0.01%
-93.7%
Q3 2016$1,158,000
+865.0%
1,246
+428.0%
0.08%
+887.5%
Q2 2016$120,000
-57.6%
236
+78.8%
0.01%
-65.2%
Q1 2016$283,000
+236.9%
132
-18.0%
0.02%
+228.6%
Q4 2015$84,000
-50.6%
161
-42.7%
0.01%
-41.7%
Q3 2015$170,0002810.01%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q2 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 127,400$1,451,0000.01%
SIMPLEX TRADING, LLC 165$187,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTRA CELLULAR THERAPIES INC shareholders